The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization

BACKGROUND/AIMS: The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which criteria provides better survival predictions in HCC patients treated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gut Liver
Main Authors: Lee, Jae Seung, Choi, Hong Jun, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Baek, Song-Ee, Chung, Yong Eun, Park, Mi-Suk, Kim, Myeong-Jin, Rhee, Hyungjin, Kim, Seung Up
Format: Artigo
Jezik:Inglês
Izdano: Editorial Office of Gut and Liver 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667935/
https://ncbi.nlm.nih.gov/pubmed/32050313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19197
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki